Doç. Dr. Aysun Şentürk Yıkılmaz
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
Myelodysplastic Syndromes 3 publicationsSource: OpenAlex / PubMed MeSHView publications
- Hodgkin Disease 2 publications
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyHaematologysaglik.gov.trFrom source
- InstitutionDenizli Devlet Hastanesisaglik.gov.trFrom source
- Area of workMyelodysplastic SyndromesExtracted from 3 publications · Model version —From source
- Publications94 publicationsOpenAlex, ORCIDFrom source
- ORCID0000-0001-5281-5955ORCIDFrom source
- Last synchronised5 November 2026 07:59https://denizlidh.saglik.gov.tr/TR-641589/doktorlarimiz.html#aysun-senturk-yikilmazsaglik.gov.tr
Scientific work
Publications on Myelodysplastic Syndromes
-
Evaluation of the frequency, risk factors, and outcomes of splanchnic vein thrombosis in myeloproliferative neoplasms: a retrospective cohort study
Journal of Thrombosis and Thrombolysis, 2026
DOI 10.1007/s11239-026-03363-8 PMID 42565930 Open-access full textSource: OpenAlex
-
Original Versus Generic Eltrombopag in Patients with Immune Thrombocytopenia: A Prospective Multi-Center Experience on Efficacy and Safety
Journal of Clinical Medicine, 2026
DOI 10.3390/jcm15020634 PMID 41598573 Open-access full textSource: ORCID
-
(PB2953) REAL-WORLD EFFICACY AND CARDIOVASCULAR SAFETY OF ACALABRUTINIB IN B-CELL MALIGNANCIES: A TURKISH MULTICENTER EXPERIENCE COMPARING FRONTLINE INITIATION VS. TRANSITION AFTER IBRUTINIB INTOLERANCE Topic: 06. Chronic lymphocytic leukemia and related disorders -Clinical
2026
DOI 10.13140/rg.2.2.20277.44000 Source: OpenAlex
-
Real-World Outcomes of Antifungal Prophylaxis in Adult Acute Lymphoblastic Leukemia Patients: A Multicenter Comparison of the Use of Fluconazole and Micafungin
Journal of Clinical Medicine, 2025
DOI 10.3390/jcm14207294 PMID 41156164 Open-access full textSource: OpenAlex
-
Real-Life Retrospective Turkiye Data of the De-Escalation of ABVD to AVD in Hodgkin Lymphoma: On Behalf of the TSH Turkish Lymphoma Study Group
Journal of Clinical Medicine, 2025
DOI 10.3390/jcm14196813 PMID 41095893 Open-access full textSource: OpenAlex
-
MİYELOPROLİFERATİF NEOPLAZMLARDA SPLANKNİK VEN TROMBOZUNUN DEĞERLENDİRİLMESİ: THD KRONİK MİYELOSİTER LÖSEMİ VE KRONİK MİYELOPROLİFERATİF NEOPLAZMLAR VE HEMOSTAZ - TROMBOZ BİLİMSEL ALT KOMİTELERİ ÇOK MERKEZ ÇALIŞMASI
Bursa Uludag University - AVESIS, 2025
Source: OpenAlex
-
MİYELOPROLİFERATİF NEOPLAZMLARDA SPLANKNİK VEN TROMBOZUNUN DEĞERLENDİRİLMESİ: THD KRONİK MİYELOSİTER LÖSEMİ VE KRONİK MİYELOPROLİFERATİF NEOPLAZMLAR VE HEMOSTAZ - TROMBOZ BİLİMSEL ALT KOMİTELERİ ÇOK MERKEZ ÇALIŞMASI
Kocaeli Üniversitesi - AVESİS, 2025
Source: OpenAlex
-
Revisiting morbidities and predictors in transfusion-dependent thalassemia: A cohort study over 10 years from the national registry of hemoglobinopathies in Türkiye
Blood, 2025
DOI 10.1182/blood-2025-4690 Source: OpenAlex
-
A Rare But Fatal Toxicity: Immune Checkpoint Inhibitor–Related Acquired Thrombotic Thrombocytopenic Purpura
Journal of Immunotherapy and Precision Oncology, 2025
DOI 10.36401/jipo-24-2 PMID 39811422 1 citation (Europe PMC) Open-access full textSource: ORCID
-
Real-World Outcomes of Antifungal Prophylaxis in Adult Acute Lymphoblastic Leukemia: A Multicenter Comparison of Fluconazole and Micafungin
2025
DOI 10.20944/preprints202509.0283.v1 Open-access full textSource: ORCID